Human_JJ
T_NN
cell_NN
activation_NN
through_IN
the_DT
activation-inducer_JJ
molecule\/CD69_NN
enhances_VBZ
the_DT
activity_NN
of_IN
transcription_NN
factor_NN
AP-1_NN
._.

The_DT
induction_NN
of_IN
the_DT
AP-1_NN
transcription_NN
factor_NN
has_VBZ
been_VBN
ascribed_VBN
to_TO
the_DT
early_JJ
events_NNS
leading_VBG
to_TO
T_NN
cell_NN
differentiation_NN
and_CC
activation_NN
._.

We_PRP
have_VBP
studied_VBN
the_DT
regulation_NN
of_IN
AP-1_NN
activity_NN
in_IN
human_JJ
peripheral_JJ
blood_NN
T_NN
lymphocytes_NNS
stimulated_VBN
through_IN
the_DT
activation_NN
inducer_NN
molecule_NN
-LRB-_-LRB-
AIM_NN
-RRB-_-RRB-
\/_:
CD69_NN
activation_NN
pathway_NN
._.

Phorbol_NN
esters_NNS
are_VBP
required_VBN
to_TO
induce_VB
AIM\/CD69_NN
cell-surface_JJ
expression_NN
as_RB
well_RB
as_IN
for_IN
triggering_VBG
the_DT
proliferation_NN
of_IN
T_NN
cells_NNS
in_IN
conjunction_NN
with_IN
anti-AIM_JJ
mAb_NN
._.

Mobility_NN
shift_NN
assays_NNS
showed_VBD
that_IN
addition_NN
of_IN
anti-AIM_JJ
mAb_NN
to_TO
PMA-treated_JJ
T_NN
lymphocytes_NNS
markedly_RB
enhanced_VBD
the_DT
binding_VBG
activity_NN
of_IN
AP-1_NN
to_TO
its_PRP$
cognate_JJ
sequence_NN
,_,
the_DT
phorbol_NN
ester_NN
response_NN
element_NN
._.

In_IN
contrast_NN
,_,
anti-AIM_JJ
mAb_NN
did_VBD
not_RB
induce_VB
any_DT
change_NN
in_IN
the_DT
binding_NN
activity_NN
of_IN
NF-kappa_NN
B_NN
,_,
a_DT
transcription_NN
factor_NN
whose_WP$
activity_NN
is_VBZ
also_RB
regulated_VBN
by_IN
protein_NN
kinase_NN
C_NN
._.

The_DT
increase_NN
in_IN
AP-1-binding_JJ
activity_NN
was_VBD
accompanied_VBN
by_IN
the_DT
marked_JJ
stimulation_NN
of_IN
the_DT
transcription_NN
of_IN
c-fos_NN
but_CC
not_RB
that_DT
of_IN
c-jun_NN
._.

Blockade_NN
of_IN
the_DT
DNA-binding_JJ
complexes_NNS
with_IN
an_DT
anti-Fos_JJ
mAb_NN
demonstrated_VBD
a_DT
direct_JJ
participation_NN
of_IN
c-Fos_NN
in_IN
the_DT
AP-1_NN
complexes_NNS
induced_VBN
by_IN
anti-AIM_JJ
mAb_NN
._.

Most_JJS
of_IN
the_DT
AP-1_NN
activity_NN
could_MD
be_VB
eliminated_VBN
when_WRB
the_DT
anti-AIM_JJ
mAb_NN
was_VBD
added_VBN
to_TO
the_DT
culture_NN
medium_NN
in_IN
the_DT
presence_NN
of_IN
cycloheximide_NN
,_,
suggesting_VBG
that_IN
de_FW
novo_FW
protein_NN
synthesis_NN
is_VBZ
crucial_JJ
for_IN
the_DT
induction_NN
of_IN
AP-1-binding_JJ
activity_NN
._.

These_DT
data_NNS
provide_VBP
the_DT
evidence_NN
that_IN
activation_NN
of_IN
human_JJ
peripheral_JJ
blood_NN
T_NN
cells_NNS
through_IN
the_DT
AIM_NN
activation_NN
pathway_NN
regulate_VBP
the_DT
activity_NN
of_IN
AP-1_NN
._.

Therefore_RB
,_,
this_DT
pathway_NN
appears_VBZ
as_IN
a_DT
crucial_JJ
step_NN
in_IN
the_DT
initiation_NN
of_IN
early_JJ
T_NN
cell_NN
activation_NN
events_NNS
._.

